Arrowstreet Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History

Arrowstreet Capital’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-32,263	Closed	-$2.02M	–	1575
2022 Q4	$2.02M	Buy	32,263 +16,784	+108%	+$1.11M	﹤0.01%	870
2022 Q3	$1.09M	Buy	+15,479	New	+$1.07M	﹤0.01%	974

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Arrowstreet Capital's AXNX Position: Q1 2023 in Review

Arrowstreet Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2023, closing a stake of 32,263 shares — an estimated $2.02M sold.

Arrowstreet Capital first reported a position in AXNX in Q3 2022 and held it in 2 quarters. The position peaked at $2.02M in Q4 2022. 236 funds tracked by Wall St. Rank hold AXNX as of Q1 2023.

Arrowstreet Capital reported no remaining Axonics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Arrowstreet Capital sold 32,263 Axonics, Inc. Common Stock shares in Q1 2023, an estimated $2.02M.
Arrowstreet Capital first reported a position in Axonics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Arrowstreet Capital's Axonics, Inc. Common Stock position peaked at $2.02M in Q4 2022.
236 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2023.

Based on Arrowstreet Capital's 13F filing for Q1 2023, filed 15 May 2023.